Alternatives
Alternatives to Lunesta 3 mg tablet
2 other presentations of Eszopiclone 3 mg tablet
There are 2 alternatives to this medicine in the catalogue: the same active ingredient (Eszopiclone), strength (3 mg) and dosage form (tablet) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Lunesta 3 mg tabletThis pageOral | Waylis Therapeutics | US FDA | 30 tablets | Store at 25°C (77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). | On request | — | Available on request |
| Eszopiclone 3 mg tabletOral | — | US FDA | 100 tablets, 30 tablets | Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). | On request | — | Available on request |
| Eszopiclone 3 mg tabletOropharyngeal | — | US FDA | 30 tablets, 60 tablets | Store at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°F to 30°C (59°F to 86°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Lunesta 3 mg tabletNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.